Printer Friendly

APPLIED BIOSCIENCE INTERNATIONAL ANNOUNCES TWO-FOR-ONE STOCK SPLIT

 APPLIED BIOSCIENCE INTERNATIONAL ANNOUNCES TWO-FOR-ONE STOCK SPLIT
 EAST MILLSTONE, N.J., April 1 /PRNewswire/ -- Dr. Kenneth H. Harper, chairman and chief executive officer of Applied Bioscience International Inc. (NASDAQ: APBI) announced that the board of directors of the company today approved a two-for-one stock split on the common stock of the company, payable, by way of a stock dividend, to holders of record on April 13, 1992. The stock distribution will be paid on April 30, 1992.
 APBI provides a broad range of inter-related services, which include biological safety testing, clinical research and development, agrochemical research and development and the assessment and management of environmental risk. The company provides such serves under contract to clients in the pharmaceutical, general chemical, agrochemical, nutritional and other industries throughout the world.
 -0- 4/1/92 R
 /CONTACT: John Timoney, vice president and CFO of Applied Bioscience International, 908-873-2550, or John McNamara of John McNamara Advertising, 212-509-7779, for Applied Bioscience International/
 (APBI) CO: Applied Bioscience International Inc. ST: New Jersey IN: MTC SU:


KW -- NY053 -- 3885 04/01/92 12:56 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 1, 1992
Words:178
Previous Article:ODESTA SYSTEMS CORPORATION SHIPS OPEN WORKFLOW AND DOCUMENT MANAGEMENT SYSTEM
Next Article:SUNBEAM-OSTER REFINANCES BANK FACILITIES
Topics:


Related Articles
U.S. BIOSCIENCE ANNOUNCES STOCK SPLIT
U.S. BIOSCIENCE ANNOUNCES STOCK SPLIT
APPLIED BIOSCIENCE INTERNATIONAL MERGES WITH PHARMACO DYNAMICS RESEARCH
APPLIED BIOSCIENCE INTERNATIONAL REPORTS FIRST FINANCIAL RESULTS SINCE RECENT MERGER WITH PHARMACO
APPLIED BIOSCIENCE INTERNATIONAL INC. ANNOUNCES STOCK REPURCHASE PROGRAM OF UP TO 1 MILLION SHARES OF COMMON STOCK
APPLIED BIOSCIENCE INTERNATIONAL INC. ANNOUNCES INCREASE IN SHARE REPURCHASE PROGRAM FROM ONE MILLION SHARES TO TWO MILLION SHARES
APPLIED BIOSCIENCE INTERNATIONAL INC. REPORTS 1993 FIRST QUARTER FINANCIAL RESULTS
U.S. BIOSCIENCE SETTLES CLASS ACTION LITIGATION
MULTINATIONAL INVESTMENT IN BAY AREA BIOSCIENCE TOTALS $10.8 BILLION
ACADIA Pharmaceuticals Completes $25 Million Private Placement; Alan G. Walton of Oxford Bioscience Partners Appointed to ACADIA's Board of Directors.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters